Yr4 Geriatrics - Study Points Flashcards
What is Dementia?
- 7 Subtypes?
- Epidemiology?
Epidemiology of Dementia Subtypes
- >90 years – mixed dementias more common.
- <65 years – greater relative incidence FTD, less vascular dementia.
- Any rapidly progressive dementia (over months) – refer to a neurological service with access to LP/EEG to examine for rarer conditions such as CJD.
- DLB = Dementia with Lewy body
- FTD = Frontotemporal dementia
- PDD = Parkinson’s disease dementia
What is the difference between a Mild Cognitive Impairment and Dementia?
- How do we make a diagnosis of dementia?
MCI or Dementia?
- Difference between mild cognitive impairment and dementia = dysfunction in ADLs
- Evidence of ‘cognitive impairment’ - subjective and objective.
- Amnestic (memory) or non-amnestic (language, attention).
- Does not affect activities of daily living.
- About 10-15% of people with MCI will develop dementia (per annum), compared to 1-2% of the older population.
- Some people with MCI will improve.
- Some people with MCI will remain static.
What are 6 Aims of a Dementia Assessment?
- Why is it important to diagnose Dementia? (6 reasons)
Aims of Dementia Assessment
1. Establish if a person has dementia.
2. Exclude other conditions that have a similar presentation, especially potentially reversible causes of cognitive impairment.
3. Establish dementia sub-type.
4. Evaluate the impact - what is the severity and extent of disability?
5. Evaluate family and social support, and the physical environment.
6. Evaluate any comorbidity.
- What are 10 common symptoms that might suggest an underlying dementia?
- 6 Cognitive Symptoms?
- 6 Psychiatric and Behavioural Symptoms?
- Dysfunction in ADL?
Common symptoms that might suggest an underlying dementia
1. Memory loss (often the first feature if Alzheimer’s dementia) – e.g., repeatedly lose items, miss appointments.
2. Confusion.
3. Repetitiveness.
4. Becoming lost in a familiar area.
5. Personality change (more irritable, inappropriate, hoarding, indifference, ritualistic behaviours).
6. Apathy and withdrawal - can be diagnosed with depression.
7. Forgetting how to use familiar household appliances or objects (suggests apraxia).
8. Not recognising objects for what they are (suggests agnosia).
9. Impaired language skills (struggle to find the right word to use, vocabulary limited and grammar poor).
10. Loss of ability to undertake everyday tasks (driving, cooking, shopping, banking, reading) - suggests a disorder of executive function.
List 10 Potentially reversible causes of cognitive impairment.
Potentially reversible causes of cognitive impairment
1. Delirium.
2. Psychiatric disease - depression, anxiety.
3. Alcohol/other substance abuse.
4. Medication - side effects (e.g., BZD, anticholinergics, psychotropics, narcotics, antiepileptics, antidepressants).
5. Neurological disease - tumours, chronic subdural.
6. Normal pressure hydrocephalus (NPH) – triad: dementia, gait disturbance, urinary incontinence
7. “Classics” - B12/folate deficiency, hypothyroid, hypercalcaemia.
8. Infections - neurosyphilis, HIV.
9. Collagen vascular disease - cerebral vasculitis.
10. Obstructive sleep apnoea.
Diagnosis of Dementia
- What history will you take?
- Collateral?
- IQCODE?
- Assessing Functional State and the Environment?
- ADLs?
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
When taking a collateral history (from someone who knows the person with suspected dementia), consider supplementing with a structured
instrument, such as the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE).
What will you look for on Physical Examination when making a diagnosis of Dementia?
“Memory Complaints” - 4 Differential Diagnoses?
How do we distinguish between the 3D’s: Delirium, Dementia, & Depression?
Are we usually using Cognitive Screening Tests as true Screening tests?
- Screening vs. Case Finding?
- List 10 Examples of cognitive screening tests?
Cognitive Screening Tests - Not “True” Screening Tests
- Screening = detection of disease amongst ‘healthy’ community members of (unsuspected) disorders or risk factors. The ideal screening test is sensitive, specific, valid, easy to administer, minimally time-consuming.
- Case Finding = Detection of cognitive impairment where there is a high probability of disease in a particular population or setting. We are usually ‘case finding’ with cognitive screening tests.
List 9 Limitations of cognitive screening tests?
- When might the results be skewed?
- MoCA versus the MMSE?
- Scores must be interpreted considering age, literacy, and education achievement.
- Intellectual and physical disabilities will affect the reading and writing components.
- Depression, anxiety and impaired concentration will also influence the score.
- Sensory impairments, language and cultural bias.
- Detect cognitive impairment from any cause.
- They are not designed to provide a comprehensive cognitive assessment.
- Do not make a definitive diagnosis of ‘dementia’ per se.
- A ‘normal’ score does not exclude the possibility of early cognitive decline.
- A ‘normal’ MMSE score can occur in FTD and DLB.
What are the Diagnostic capability of MMSE cognitive screening test?
- Would a score of 30/30 rule out dementia?
- Would a score of ≤ 24/30 confirm a
diagnosis of dementia?
Diagnostic capability of MMSE cognitive screening test
- Comparison with normative values may not detect mild decline in high functioning individuals (or falsely detect dementia in individuals with life-long poor cognitive function).
- Can be poor at detecting mild dementia.
- A score on an MMSE may vary by a few points between assessors, times of day, locations. Small differences are considered insignificant.
- When might you consider Neuropsychological Testing for Dementia Diagnosis?
- What are the indications for a Psychiatry Review (Psychogeriatrician) when making a dementia diagnosis?
Neuropsychological Testing - Not required in all cases.
1. When diagnosis is uncertain or there are atypical features.
2. Especially in younger onset.
3. Especially if possibility of depression (or similar).
4. Can form a baseline for monitoring.
5. Formal extensive cognitive testing of multiple domains.
6. Can help establish subtype if unclear.
BPSD = Behaviours and psychological symptoms of dementia
Dementia Work-up
- 10 Laboratory Tests?
- Role of Neuroimaging? 3 characteristic changes?
- 4 Additional Investigations?
Dementia Work-up: Neuroimaging
- Structural Neuroimaging (CT/MRI): Shape, Position, Volume of Brain Tissue? Patterns of shrinkage?
- Functional and Metabolic Neuroimaging? Examples?
How would you go about Informing a Diagnosis of Dementia?
What are the DSM-5 Diagnostic Criteria (2013) for a Major and Minor Neurocognitive Disorder (NCD)?
- 6 Cognitive Domains described in the DSM-5?
DSM-5 Diagnostic Criteria (2013)
Minor NCD - Deficits do not interfere with ADLs (equivalent to MCI, prodromal dementia)
- IADLs (referring to more complex tasks, such as paying bills or managing medications) are preserved, but greater effort, or compensatory strategies, or accommodation may be required to maintain independence.
Major NCD- Deficits sufficient to interfere with ADLs. (equivalent to dementia)
- Requires (at least) minimal assistance with IADLs.
9 Dementia Subtypes/Causes of Neurocognitive disorder according to DSM-5?
- Alzheimer’s disease (AD)
- Vascular neurocognitive disorder
- Frontotemporal (FTD) neurocognitive disorder
- Neurocognitive disorder due to Traumatic brain injury (TBI)
- Lewy body dementia (DLB),
- Parkinson’s disease (PDD)
- HIV infection
- Substance-induced neurocognitive disorder
- Neurocognitive disorder due to Huntington’s disease (HD), Prion disease (CJD), or to another medical condition; and neurocognitive disorder not elsewhere classified
Alzheimer’s Dementia
- Incidence?
- Life expectancy?
- Contributing Factors?
- Characteristics of Early stages?
- Characteristics of Later stages?
- Cognitive deficits?
- Natural History and associated MMSE score?
Outline the pathology of Alzheimer’s Dementia.
Vascular Dementia
- Incidence?
- Symptoms?
- When is the term used?
- Course?
- What is diagnosis based on?
- 2 Subtypes?
- The term ‘Vascular dementia’ is used when cognitive deficits are severe enough to interfere with daily activities and function.
- Cognitive deterioration can occur ‘step wise’ (with repeated larger vessel occlusions) or gradually (likely multiple small vessel occlusions which are lacunes or WM lesions).
- Do not diagnose Vascular Dementia purely based on vascular imaging burden.
What 11 thing might make you suspect a diagnosis of Vascular Dementia vs. Alzheimer’s Dementia?
Dementia with Lewy Bodies (DLB)
- Course?
- Symptoms?
- Pathology?
- Vs. Alzheimer’s Dementia?
- Which meds to avoid? What to use to treat distressing hallucinations?
Fronto-Temporal Dementia
- Incidence?
- Symptoms?
- Age groups?
- Pathology?
Parkinson’s Disease Dementia
- Clinical features?
- Meds?
Normal Pressure Hydrocephalus
- Triad?
- Findings: CT brain? MRI brain?
- Gait Apraxia? Opening pressure on LP?
Normal Pressure Hydrocephalus - “Gait Apraxia”
- Impaired initiation.
- Magnetic (feet appear as if ‘stuck’ to the floor)
- May improve markedly after a few steps.
- Slow, shuffling, wide-based, poor turning.
- Can perform gait-related leg movements when lying in bed (i.e. it is an apraxia – motor is ok)
- Normal opening pressure on LP.
What are the General Principles of Management of Dementia?
Pharmacotherapy for Alzheimer’s Dementia
- 3 Treatment Targets?
- 2 Options for Cognitive Symptoms?
Role of Cholinesterase Inhibitors in Dementia
- How do they work?
- Main side effects?
- Contraindications?
- Evidence in different subtypes?
Pharmacotherapy for Alzheimer’s Dementia - Treatment Targets
1. Underlying Disease (none yet).
2. Cognitive symptoms
* Cholinesterase inhibitors
* Memantine (NMDA receptor antagonist)
3. Non-cognitive symptoms (e.g.
behavioural and psychological symptoms).
Pharmacological Treaments of Dementia: Memantine (Ebixa)
- MOA?
- Side effects?
- Efficacy?
What are the Behavioural and Psychological Symptoms of Dementia (BPSD)? (10)
- General Management Principles of BPSD?
BPSD - Non-cognitive symptoms of dementia
- Tend to occur late
- Common, may be very distressing.
1. Agitation
2. Aggression
3. Delusions
4. Hallucinations
5. Shouting
6. Touching
7. Wandering
8. Pacing
9. Insomnia
10. Withdrawal
Pharmacotherapy for BPSD
- First-line?
- Risks vs. Benefits?
- 6 Key Messages?
- Which agents? Dosing?
Functions of the Brain: Linking anatomy with pathology
- Frontal Lobe?
- Temporal Lobe?
- Parietal Lobe?
- Occipital Lobe?
Memory
- Definition?
- Which parts of the brain control memory?
- What is Registration?
- What is Short term memory? How to test it?
- What is Long-term memory? 2 Types and how to test them each?
- What is Episodic memory? Examples? How do we test it?
Memory
- Definition: Process of learning involving the registration of information, storage of that information, and the retrieval of the information at a later time.
- Memory is a mesial temporal lobe and hippocampal function.
Memory Impairment in Dementia
- What type is usually affected first?
- Changes to memory in Vascular Dementia vs. Alzheimer’s Dementia?
Memory Impairment in Dementia
* Impairment of memory tends to be the first feature of Alzheimer’s disease.
* Memory impairment may follow general intellectual decline in Vascular Dementia.
* People with Alzheimer’s dementia: Learn slower, learn less, Recognise poorly, Forget more quickly.
* Anterograde Memory (new learning) is affected first, often with better preservation of Retrograde Memory (memory for past events). i.e. can remember the past well but cannot remember three words after a few minutes (poor recall).
* Impairment of episodic memory commonly seen in Alzheimer’s disease (also MCI, PDD, depression).
Parkinson’s Disease
- Epidemiology: Incidence? Mean age at diagnosis? Prevalence? Mortality?
- Risk factors: 7 Increased? 5 Decreased?
Epidemiology
- Second most common neurodegenerative disorder after Alzheimers.
- Incidence increases rapidly after 60 years of age.
- Mean age at diagnosis 70.5 years.
- Prevalence 0.3% general population, 1% over 65 years of age.
- Mortality 2-5 x higher than age-matched controls.
Parkinson’s Disease: Pathophysiology
- Basal Ganglia Circuits?
Pathophysiology
- Lewy (1912) – presence of cytoplasmic inclusion bodies in neurons in various brain region
- Tretiakoff (1919) – loss of neurons in substantia nigra
- 1950s – dopamine depletion in basal ganglia
- Idiopathic
- Genetics– mostly sporadic, first-degree relatives 2.3 times higher risk (ask family history)
Clinical Features of Parkinson’s Disease
- 4 Motor?
- 4 Non-Motor?
Clinical Features
Motor
1. Tremor (typically resting) - Unilateral tremor is the most common presenting symptom and sign.
3. Rigidity (may be cogwheel or lead-pipe).
4. Bradykinesia - Prior symptoms may include difficulties writing, doing up buttons, a feeling of stiffness or slowness, voice fluctuations.
5. Postural instability.
Non-Motor: Sensory, autonomic, neuropsychiatric, sleep.
Describe the Parkinsonian Gait - 5 Features?
Parkinsonian Gait
1. Difficulty getting up from chair/bed.
2. Initial apraxia/freezing.
3. Stooped posture, reduced arm swing.
4. Short and rapid steps – festination.
5. Difficulty stopping and turning around.
Motor features of Parkinson’s Disease
- 4 Cardinal manifestations?
- 5 Craniofacial?
- 5 Visual?
- 5 MSK?
- Gait?
What are the Non-Motor Symptoms of Parkinson’s Disease?
- 2 Sensory?
- 4 Autonomic Dysfunction?
- 6 Neuropsychiatric?
- 5 Sleep Disorders?
Non-Motor Symptoms (NMS)
- Very common, about 97% of patient in a multicentre study reported NMS.
- Each patient experiencing average of eight NMS.
- Often affect QOL more than motor symptoms.
Neuropsychiatric Symptoms of Parkinson’s Disease
- 1) Depression?
- 2) Anxiety?
- 3) Apathy?
- 4) Cognitive Impairment?
- 5) Psychosis and Hallucinations?
Sleep Disorders in Parkinson’s Disease
- 1) Excessive Daytime Sleepiness (EDS)?
- 2) Restless Leg Syndrome (RLS)?
- 3) REM sleep Behaviour Disorder (RBD)?
Sleep Disorders in Parkinson’s Disease
- Sleep difficulty – most common NMS as reported by PD patients.
- Significant effect on QOL.
- Most common sleep disturbance reported by patients is Sleep Fragmentation and Early Morning Awakening.
- Causes - nocturia, difficulty turning over in bed, cramps, vivid dreams, pain, dystonia and depression.
- ‘Sleep disorders’ include:
4 Symptoms of Autonomic Dysfunction in Parkinson’s Disease?
- Natural History of PD?
Autonomic Dysfunction in PD
1. Postural Hypotension – in up to 60% of patients. Could be due to drugs. Increases risk of falls
2. Urinary problems – frequency, nocturia, urgency and urge incontinence – reduced bladder capacity due to involuntary detrusor contraction.
3. Constipation– slow colonic transit, very common and important as it interferes with drug absorption.
4. Sexual Dysfunction – decreased interest and low drive due to depression, fatigue, bradykinesia and rigidity. Excessive sexual drive can be associated with medications.
Diagnosing Parkinson’s Disease
- Diagnostic Criteria?
- 4 Supportive Criteria?
- 9 Absolute Exclusion Criteria?
- 9 Red Flags?
Absolute Exclusion Criteria
1. Cerebellar abnormalities.
2. Gaze palsy.
3. Diagnosis of probable behavioural variant FTD or PPA.
4. Lower limb parkinsonism for more than three years.
5. Treatment with a dopamine antagonist.
6. Absence of observable response to high-dose levodopa.
7. Unequivocal cortical sensory loss, clear limb ideomotor apraxia, or progressive aphasia.
8. Normal functional neuroimaging of the presynaptic dopaminergic system.
9. Documentation of an alternative condition known to produce
parkinsonism.
- Which investigations would you consider in the diagnosis of PD?
- When is idiopathic PD unlikely? (11 points)
Investigations
1. Cranial Imaging done to exclude specific structural abnormalities (eg, hydrocephalus, tumour, or lacunar infarcts).
2. DaTscan – Dopamine Transporter Scan (diagnostic method to look for loss of dopaminergic neurons in the striatum). Parkinsonism vs ET but cannot differentiate PD vs Parkinson’s-plus.
3. MIBG scan – tests cardiac sympathetic denervation. Relatively sensitive and specific in differentiating PD vs. Parkinson’s-plus.
What is the Unified Parkinson’s Disease Rating Scale (UPDRS)?
- 6 Components?
- Motor Staging – Hoen and Yahr?
Management of PD
- 5 Medications? MOA?
- Surgical?
- MDT?
- Principles of Initiating Therapy?
Management of PD
Medications
1. Levodopa
2. Dopamine Agonists
3. MAO-B inhibitors
4. Anticholinergics
5. Catechol-O-methyl transferase (COMT) inhibitors
Surgical - DBS
PD Multidisciplinary team management
- PT, OT, Nurse, Doctor, Speech Pathologist, Dietician, Social
Work, Clinical Psychologist
Pharmacological Treatment of PD: Levodopa
- Which symptoms is it most helpful for?
- What is it usually combined with?
- Adverse effects?
- Motor Fluctations?
Levodopa
- Most effective drug therapy.
- Very effective for bradykinesia, helps with rigidity and tremors (not so much for postural instability).
- Usually combined with a peripheral decarboxylase inhibitor (Carbidopa/benserazide) to block conversion to dopamine in the systemic circulation and liver (before it crosses the blood-brain barrier)..
- Available as immediate release or controlled release.
Pharmacological Treatment of PD: Dopamine Agonists
- 3 Examples?
- Useful for?
- Adverse Effects?
- Dopamine Dysregulation Syndrome?
Pharmacological Treatment of PD: MOA-B Inhibitors
- 2 Examples?
- Drug interactions?
Dopamine Agonists - Adverse Effects:
1. Nausea, vomiting, somnolence, postural hypotension, confusion, hallucinations, psychosis.
2. Excessive sleepiness and “sleep attacks”
3. Impulse control disorders (gambling, shopping) – warn.
4. Dopamine Dysregulation Syndrome
- Compulsive use of dopaminergic drugs despite dyskinesias.
- More common younger onset, male.
- Dopaminergic agents cause mood elevation with withdrawal effects with lower doses.
- Impulse control disorder may accompany DDS.
- DA > levodopa
Pharmacological Treatment of PD: COMT Inhibitors
- 2 Examples?
- MOA?
- Adverse Effects?
- 2 Other Medications?